Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Fulcrum Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +35 vs. Q2 2021
- Shares held
- 36.6M
- +9.75M (+36.4%) vs. Q2 2021
- Total value
- $1.03B
- +$750.7M (+267.3%) vs. Q2 2021
- New holders
- 43
- 35 more added
- Sold out
- 8
- 16 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 6,044,763 | $170.5M | 0.01% | +3,665,282+154.0% | Added |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −1,154,476−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −213,533−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −162,700−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −77,477−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −29,050−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −12,699−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,773−100.0% | Sold out |
| Smith Asset Management Group LP | – | – | – | – | Not filed |